Screener
CG Oncology CGON Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:ReceivablesNetCurrent.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's accounts receivable?
- CG Oncology (CGON) reported accounts receivable of $417K in Q2 2026.
- How has CG Oncology's accounts receivable changed year-over-year?
- CG Oncology's accounts receivable decreased by 25.8% year-over-year, from $562K to $417K.
- What is the long-term trend for CG Oncology's accounts receivable?
- Over 2 years (2023 to 2025), CG Oncology's accounts receivable has grown at a 173.5% compound annual growth rate (CAGR), from $92K to $688K.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about CG Oncology's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude